About this trial
The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.
Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.
Disqualifiers
Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
Trial population
All women diagnosed with cancer for whom a fertility preserving cancer treatment is applied will be considered for inclusion.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Fertility Outcome
pregnancy rate
Secondary outcomes
Oncological Outcome
Recurrence of cancer
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Gasthuisberg
Lead sponsor
NKI-AvL
Collaborator
Medical University of Vienna
Collaborator
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborator
Oslo University Hospital
Collaborator
Haukeland University Hospital
Collaborator
N.N. Blokchin NMRCO
Collaborator